CDA and cancer: This finding was corroborated by immunohistochemistry for CDA in an independent cohort of 63 human treatment-naive PDAC samples (referred to as cohort 1, stage I–III; N0–N2; Supplementary Table 1), revealing variable but selective expression of CDA in cancer cells but not in adjacent nontumor tissue (Fig. 1c).